FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3140305494> ?p ?o ?g. }

• W3140305494 abstract "Abstract Chemotherapeutic drugs suffer from non-specific binding, undesired toxicity, and poor blood circulation which contribute to poor therapeutic efficacy. In this study, antibody–drug nanoparticles (ADNs) are engineered by synthesizing pure anti-cancer drug nanorods (NRs) in the core of nanoparticles with a therapeutic monoclonal antibody, Trastuzumab on the surface of NRs for specific targeting and synergistic treatments of human epidermal growth factor receptor 2 (HER2) positive breast cancer cells. ADNs were designed by first synthesizing ~ 95 nm diameter × ~ 500 nm long paclitaxel (PTX) NRs using the nanoprecipitation method. The surface of PTXNRs was functionalized at 2′ OH nucleophilic site using carbonyldiimidazole and conjugated to TTZ through the lysine residue interaction forming PTXNR-TTZ conjugates (ADNs). The size, shape, and surface charge of ADNs were characterized using scanning electron microscopy (SEM), SEM, and zeta potential, respectively. Using fluorophore labeling and response surface analysis, the percentage conjugation efficiency was found > 95% with a PTX to TTZ mass ratio of 4 (molar ratio ≈ 682). In vitro therapeutic efficiency of PTXNR-TTZ was evaluated in two HER2 positive breast cancer cell lines: BT-474 and SK-BR-3, and a HER2 negative MDA-MB-231 breast cancer cell using MTT assay. PTXNR-TTZ inhibited > 80% of BT-474 and SK-BR-3 cells at a higher efficiency than individual PTX and TTZ treatments alone after 72 h. A combination index analysis indicated a synergistic combination of PTXNR-TTZ compared with the doses of single-drug treatment. Relatively lower cytotoxicity was observed in MCF-10A human breast epithelial cell control. The molecular mechanisms of PTXNR-TTZ were investigated using cell cycle and Western blot analyses. The cell cycle analysis showed PTXNR-TTZ arrested > 80% of BT-474 breast cancer cells in the G2/M phase, while > 70% of untreated cells were found in the G0/G1 phase indicating that G2/M arrest induced apoptosis. A similar percentage of G2/M arrested cells was found to induce caspase-dependent apoptosis in PTXNR-TTZ treated BT-474 cells as revealed using Western blot analysis. PTXNR-TTZ treated BT-474 cells showed ~ 1.3, 1.4, and 1.6-fold higher expressions of cleaved caspase-9, cytochrome C, and cleaved caspase-3, respectively than untreated cells, indicating up-regulation of caspase-dependent activation of apoptotic pathways. The PTXNR-TTZ ADN represents a novel nanoparticle design that holds promise for targeted and efficient anti-cancer therapy by selective targeting and cancer cell death via apoptosis and mitotic cell cycle arrest." @default.
• W3140305494 created "2021-04-13" @default.
• W3140305494 creator A5006347876 @default.
• W3140305494 creator A5040302062 @default.
• W3140305494 creator A5041786790 @default.
• W3140305494 creator A5051519834 @default.
• W3140305494 creator A5083946093 @default.
• W3140305494 date "2021-04-01" @default.
• W3140305494 modified "2023-10-02" @default.
• W3140305494 title "Antibody–drug nanoparticle induces synergistic treatment efficacies in HER2 positive breast cancer cells" @default.
• W3140305494 cites W1538955534 @default.
• W3140305494 cites W1692977678 @default.
• W3140305494 cites W1804680040 @default.
• W3140305494 cites W1890121728 @default.
• W3140305494 cites W1921766784 @default.
• W3140305494 cites W1965946277 @default.
• W3140305494 cites W1965958391 @default.
• W3140305494 cites W1967637067 @default.
• W3140305494 cites W1972063621 @default.
• W3140305494 cites W1974088439 @default.
• W3140305494 cites W1976027404 @default.
• W3140305494 cites W1977341513 @default.
• W3140305494 cites W1977345614 @default.
• W3140305494 cites W1977457835 @default.
• W3140305494 cites W1979628630 @default.
• W3140305494 cites W1980250464 @default.
• W3140305494 cites W1984007340 @default.
• W3140305494 cites W1984548348 @default.
• W3140305494 cites W1985882425 @default.
• W3140305494 cites W1991233540 @default.
• W3140305494 cites W1992435071 @default.
• W3140305494 cites W1995139161 @default.
• W3140305494 cites W1996778928 @default.
• W3140305494 cites W1997435827 @default.
• W3140305494 cites W1998412499 @default.
• W3140305494 cites W1998642504 @default.
• W3140305494 cites W2000877238 @default.
• W3140305494 cites W2007877171 @default.
• W3140305494 cites W2010413333 @default.
• W3140305494 cites W2012883222 @default.
• W3140305494 cites W2015497529 @default.
• W3140305494 cites W2017653709 @default.
• W3140305494 cites W2019165947 @default.
• W3140305494 cites W2021074776 @default.
• W3140305494 cites W2027237928 @default.
• W3140305494 cites W2027505922 @default.
• W3140305494 cites W2027866118 @default.
• W3140305494 cites W2037013151 @default.
• W3140305494 cites W2037834300 @default.
• W3140305494 cites W2038295804 @default.
• W3140305494 cites W2038348947 @default.
• W3140305494 cites W2041107116 @default.
• W3140305494 cites W2041914114 @default.
• W3140305494 cites W2051992129 @default.
• W3140305494 cites W2054745605 @default.
• W3140305494 cites W2055892918 @default.
• W3140305494 cites W2056405796 @default.
• W3140305494 cites W2057713121 @default.
• W3140305494 cites W2059223510 @default.
• W3140305494 cites W2059422902 @default.
• W3140305494 cites W2064349006 @default.
• W3140305494 cites W2064495391 @default.
• W3140305494 cites W2067278028 @default.
• W3140305494 cites W2070901146 @default.
• W3140305494 cites W2072198924 @default.
• W3140305494 cites W2077028619 @default.
• W3140305494 cites W2077431908 @default.
• W3140305494 cites W2077945404 @default.
• W3140305494 cites W2081095452 @default.
• W3140305494 cites W2083483697 @default.
• W3140305494 cites W2083738265 @default.
• W3140305494 cites W2083906562 @default.
• W3140305494 cites W2084787806 @default.
• W3140305494 cites W2090294646 @default.
• W3140305494 cites W2091269867 @default.
• W3140305494 cites W2092201159 @default.
• W3140305494 cites W2094911149 @default.
• W3140305494 cites W2095016306 @default.
• W3140305494 cites W2095633632 @default.
• W3140305494 cites W2096439168 @default.
• W3140305494 cites W2098775844 @default.
• W3140305494 cites W2099818615 @default.
• W3140305494 cites W2100014422 @default.
• W3140305494 cites W2101129444 @default.
• W3140305494 cites W2101936371 @default.
• W3140305494 cites W2104558356 @default.
• W3140305494 cites W2107660675 @default.
• W3140305494 cites W2116075431 @default.
• W3140305494 cites W2117630026 @default.
• W3140305494 cites W2124935141 @default.
• W3140305494 cites W2125871683 @default.
• W3140305494 cites W2128782370 @default.
• W3140305494 cites W2132872213 @default.
• W3140305494 cites W2133700209 @default.
• W3140305494 cites W2134435289 @default.
• W3140305494 cites W2138445223 @default.
• W3140305494 cites W2146384083 @default.
• W3140305494 cites W2149773268 @default.
• W3140305494 cites W2149908785 @default.
• W3140305494 cites W2150244588 @default.

• next